SEC Form 4 · accession 0001127602-17-009677
Bioverativ Inc. · BIVV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Diantha Duvall
Officer — Chief Accounting Officer
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681689
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 28, 2017 | A | 3,360 | $0.00 | A | 3,369 | D | |
| Common StockF3 | Feb 28, 2017 | F | 211 | $47.76 | D | 3,158 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock OptionF4 | $52.08 | Feb 28, 2017 | A | 7,030 | A | — | Feb 28, 2027 | Common Stock | 7,030 | 7,030 | D |
Explanation of responses
- F1Includes restricted stock units granted by Bioverativ Inc. ("Bioverativ") to the reporting person as a result of the conversion of existing Biogen Inc. ("Biogen") restricted stock units held by the reporting person prior to the spin-off of Bioverativ from Biogen on February 1, 2017 ("Spin-Off"), as set forth in an employee matters agreement entered into between Bioverativ and Biogen in connection with the Spin-Off. Restricted stock units that are unvested continue to vest on the dates of the original Biogen awards.
- F2Includes 9 shares acquired in a pro rata distribution by Biogen in connection with the Spin-Off.
- F3Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units.
- F4This option vests in full on the third anniversary of the date of grant.